Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
3 hedge funds and large institutions have $15.1K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.
8.6% less ownership
Funds ownership: 8.71% → 0.1% (-8.6%)
40% less funds holding
Funds holding: 5 → 3 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
99% less capital invested
Capital invested by funds: $1.35M → $15.1K (-$1.33M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$8.37K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$993K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$262K |
| 3 |
Jane Street
New York
|
-$90.5K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$4K |
| 5 |
Morgan Stanley
New York
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
AlphaMark Advisors
Ft. Wright,
Kentucky
| $8K | +$8.37K | +1,000 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $7.11K | +$7.24K | +865 | New |
|
|
3
Morgan Stanley
New York
| $11 | -$8 | -1 | -50% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$993K | -128,111 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$262K | -33,769 | Closed |
|
|
6
Jane Street
New York
| – | -$90.5K | -11,682 | Closed |
|
|
7
Simplex Trading
Chicago,
Illinois
| – | -$4K | -557 | Closed |
|
PILL Hedge Fund Activity: Q1 2024 in Review
3 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q1 2024, worth a combined $15.1K — down 99% from $1.35M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PILL and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was AlphaMark Advisors, opening a new position worth an estimated $8.37K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $993K sold.
- 3 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q1 2024, down from 5 in Q4 2023.
- Funds reported $15.1K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q1 2024, down 99% quarter-over-quarter.
- 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q1 2024 and 4 closed out, a net change of -2 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q1 2024 was AlphaMark Advisors, an estimated $8.37K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q1 2024 was Susquehanna International Group, an estimated $993K sold.
Based on aggregated 13F filings for Q1 2024.